Kymera Therapeutics, Inc. (KYMR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All

Quarterly Annual TTM

Revenue Quarterly

Gross Profit Quarterly

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

Net Income Quarterly

Cost of Revenue Quarterly

Operating Cash Flow Quarterly

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.